The most serious motivation for the development of a blood substitute is the worldwide shortage of safe and viable allogeneic donor blood. Preface.

Napolitano Lena M

Department of Surgery University of Michigan Medical Center, 1C421 University Hospital, Ann Arbor, MI 48109-0033, USA.

Crit Care Clin. 2009 Apr;25(2):xi-xii. doi: 10.1016/j.ccc.2009.02.002.

Abstract

摘要

相似文献

Crit Care Clin. 2009 Apr;25(2):xi-xii. doi: 10.1016/j.ccc.2009.02.002.

Crit Care Clin. 2009 Apr;25(2):279-301, Table of Contents. doi: 10.1016/j.ccc.2009.01.003.

Science. 2002 Feb 8;295(5557):1002-5. doi: 10.1126/science.1068443.

Sheng Wu Gong Cheng Xue Bao. 2006 Jan;22(1):7-18.

Biotechnol J. 2006 Mar;1(3):333-45. doi: 10.1002/biot.200500049.

Artif Cells Blood Substit Immobil Biotechnol. 2007;35(2):149-56. doi: 10.1080/10731190601188216.

Curr Hematol Rep. 2004 Mar;3(2):92-6.

Crit Care Clin. 2009 Apr;25(2):303-10, Table of Contents. doi: 10.1016/j.ccc.2008.12.009.

Crit Care Clin. 2009 Apr;25(2):311-24, Table of Contents. doi: 10.1016/j.ccc.2008.12.011.

Crit Care Clin. 2009 Apr;25(2):399-414, Table of Contents. doi: 10.1016/j.ccc.2008.12.007.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。